My personal highlights of ESMO 2016
نویسندگان
چکیده
Results of several clinically relevant studies were presented at the 2016 Annual Meeting of the European Society of Medical Oncology (ESMO). This article summerizes the personal highlights of three medical oncologists in their respective areas of expertise.
منابع مشابه
ESMO 2017—my personal highlights
This article is not intended to be a comprehensive review of all highlights presented at the recent ESMO Annual Meeting, but rather a summary from a personal point of view in three very different fields of oncology. Breast cancer and lung cancer are traditionally in the focus of interest, and again, relevant new data were presented. The third part of this overview is focused on novel treatment ...
متن کاملHighlights for ESMO 40: celebration review for lifetime achievement awards
Correspondence to Dr Nagahiro Saijo; [email protected] SUMMARY My work, my crucial achievement, has been in the management of the transition of the conduct of cancer research/management from basic researchers/surgeons to medical oncologists (figure 1). This transition can be divided into four categories: 1. The development, progression and consolidation of global Medical Oncology in Asian countr...
متن کاملESMO gave me a chance to help make a difference: a personal reflection on the occasion of receiving the 2015 ESMO Award
On the occasion of receiving the ESMO 2015, Prof Nathan Cherny reflects on the potential of the individual clinician to address issues of consequence on a wider scale through the auspices of a professional medical society. He describes his 20 year relationship with ESMO illustrating the potential of harnessing the power of ESMO to influence care, professional behaviours and distributional justi...
متن کاملESMO Women for Oncology 2016: a very personal tale of my professional life in Asia
In Thailand, 30 years ago, when I started my career as the first medical oncologist at the Faculty of Medicine, Chiang Mai University, cancer was considered to be an incurable disease and treatment with chemotherapy was generally considered ineffective. In the Department of Medicine, the only cancers that received chemotherapy were the haematological malignancies, and these were treated by haem...
متن کاملCSCO joins ESMO Open—Cancer Horizons
Correspondence to Dr Christoph C Zielinski; christoph.zielinski@ meduniwien.ac.at ESMO Open—Cancer Horizons is happy to announce its association with the Chinese Society of Clinical Oncology (CSCO). After intensive personal contacts between the CSCO President Professor Y-LW and the leadership of the European Society for Medical Oncology (ESMO) as well as the Editor-in-Chief of ESMO Open—Cancer ...
متن کامل